Leukemia cutis originating in the extravasation site of i.v. gabexate mesilate infusion.
نویسندگان
چکیده
Leukemia cutis is a localized or disseminated skin infiltration by leukemic cells. A 64-year-old man was diagnosed with acute myeloid leukemia (AML) complicated by disseminated intravascular coagulation. During the course of treatment with gabexate mesilate, the substance accidentally leaked from the infusion site in his elbow. One month later, a dark red erythema and induration accompanied by severe pain appeared in the area proximal to the gabexate mesilate injection site. The biopsy specimen demonstrated not only inflammation but infiltration of leukemic cells as well. Immunohistochemical staining for intercellular adhesion molecule-1 and platelet/endothelial cell adhesion molecule-1 showed strong expression of endothelial cells and leukemic cells. We speculate that the gabexate mesilate might have played a role in the induction of leukemia cutis via adhesion molecules in our case.
منابع مشابه
EVALUATION OF INJECTABLE GENERIC DRUGS USING THERMOGRAVIMETRY AND THE INFLUENCE OF d-MANNOTOL ON THE STABLITLY OF GABEXATE MESILATE
Gabexate mesilate has been mainly used in the treatment of disseminated intravascular coagration (DIC) in Japan since 1983. Recently, several generic versions of injectable gabexate mesilate with or without d-mannitol as an additive have been put on the Japanese market. In our study, thermo gravimetry (TG) did not show any differences between gabexate mesilate products with or without d-mannito...
متن کاملPharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
BACKGROUND The identification of therapeutic agents that can prevent the pancreatic injury after endoscopic retrograde cholangiopancreatography (ERCP) is of considerable importance. METHODS We performed a meta-analysis including 28 clinical trials on the use of somatostatin (12 studies), octreotide (10 studies), and gabexate mesilate (6 studies) after ERCP. Outcome measures evaluated were the...
متن کاملEVALUATION OF INJECTABLE GENERIC DRUGS USING THERMOGRAVIMETRY AND THE INFLUENCE OF d-MANNITOL ON THE STABLITLY OF GABEXATE MESILATE
Gabexate mesilate has been mainly used in the treatment of disseminated intravascular coagration (DIC) in Japan since 1983. Recently, several generic versions of injectable gabexate mesilate with or without d-mannitol as an additive have been put on the Japanese market. In our study, thermo gravimetry (TG) did not show any differences between gabexate mesilate products with or without d-mannito...
متن کاملAntitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations
The employment of anti-epidermal growth factor receptor (EGFR) antibodies represents a backbone of the therapeutic options for the treatment of metastatic colorectal cancer (mCRC). However, this therapy is poorly effective or ineffective in unselected patients. Mutations in KRAS, BRAF and PIK3CA genes have recently emerged as the best predictive factors of low/absent response to EGFR-targeted t...
متن کاملChanges in blood viscosity with synthetic protease inhibitors.
We examined the effects on whole blood viscosity and coagulation time of various dosages of the synthetic low-molecular protease inhibitors gabexate mesilate and nafamostat mesilate with an oscillation-type viscometer. When either agent was added, blood viscosity decreased dose-dependently along a sigmoid-like curve. Furthermore, coagulation time was shorter with gabexate mesilate than with naf...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of dermatology
دوره 35 1 شماره
صفحات -
تاریخ انتشار 2008